Aurobindo Pharma

Hyderabad, IndiaUnclaimed profile

7Medicines listed

0Certifications

4Facilities

0Export markets

Aurobindo Pharma Limited, founded in 1986 and headquartered in Hyderabad, is a vertically integrated pharmaceutical company that develops, manufactures, and commercializes generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables globally in over 150 countries. The company operates 18 formulation facilities and 13 API facilities with manufacturing capabilities spanning solids, liquids, and specialty products, producing over 60 billion formulation units and 19,000 MT of active pharmaceutical ingredients annually. With a portfolio of 830 US ANDA filings and over 1,500 scientific experts, Aurobindo is committed to providing affordable, high-quality medicines and has a strong pipeline of biosimilar programs.

Medicines & products

Abacavir + Lamivudine TabletsAbacavir; Lamivudine

Antiretroviral · tablet · 600 mg + 300 mg · 30's

RxRegistered in 1 market

Abacavir Oral SolutionAbacavir

Antiretroviral · oral solution · 20 mg/ml · 240 ml

RxRegistered in 1 market

Abacavir TabletsAbacavir

Antiretroviral · tablet · 300 mg · 60's

RxRegistered in 1 market

Dolutegravir TabletsDolutegravir

Antiretroviral · tablet · 50 mg · 30's and 90's

RxRegistered in 1 market

Efavirenz TabletsEfavirenz

Antiretroviral · tablet · 600 mg · 30's

RxRegistered in 1 market

Lopinavir + Ritonavir TabletsLopinavir; Ritonavir

Antiretroviral · tablet · 100 mg + 25 mg · 60's

RxRegistered in 1 market

Nevirapine Oral SuspensionNevirapine

Antiretroviral · oral suspension

RxRegistered in 1 market

Product list is informational, aggregated from public sources — availability is confirmed per-deal through verified offers, not public listings.

Documents & downloads

Press Release - Aurobindo Pharma Inaugurates TheraNym - Pioneering Indias Large-Scale Biologics Contract Manufacturing FacilityPDF · provided by Aurobindo PharmaPress Release - Aurobindo Pharma receives USFDA approval for Dextromethorphan Polistirex Extended-Release Oral Suspension, 30 mg5 mL OTCPDF · provided by Aurobindo PharmaPress Release - Aurobindo Pharma receives USFDA approval for Glycerol Phenylbutyrate Oral Liquid,1.1 grams per mLPDF · provided by Aurobindo Pharma

Capabilities

Dosage forms

CreamDry Powder SuspensionEmulsionHard Gelatin CapsuleLiquid in Hard Gelatin CapsuleMultilayer TabletOintmentOsmotic drug deliveryPellets & GranulesPellets in Hard Gelatin CapsuleSolutionSuspensionTablet - Delayed ReleaseTablet - Immediate ReleaseTablet - Modified ReleaseTablet in Tablet

APIs

Semi-synthetic Penicillins

Therapeutic areas

HIV/AIDS

Services

Biosimilar developmentVertical integration - fill to finish

Facilities

Registered Office

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad, India

Corporate Office

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Rangareddy District, Hyderabad, India

Penicillin-G Facility

Kakinada, India

Pondicherry Manufacturing Unit

Pondicherry, India

Facility & product gallery

Sourcing from Aurobindo Pharma through PharmaGlobal

01Submit your requirement

Product, quantity, destination, and documents — in any of 23 languages.

02We review first

Every requirement passes a first-look review before any supplier exposure.

03Compare verified offers

Price, lead time, documents, and risk — side by side in a private deal room.

Data sources: Company disclosures. Last updated June 11, 2026. Profile data is aggregated from public regulatory registries and company disclosures. PharmaGlobal provides sourcing workflow tools; participants remain responsible for their own regulatory and trade compliance. Inaccurate? Report a correction.